Highlight
- Semaglutide use in diabetic patients on maintenance hemodialysis is associated with lower mortality and hospitalization rates compared to dulaglutide or liraglutide.
- At one year, semaglutide resulted in significantly greater body weight reduction than dulaglutide or liraglutide.
- Direct comparisons suggest semaglutide outperforms dulaglutide, though the mortality benefits versus liraglutide remain less definitive.
Study Background
Specialty calculators
For clinical reference; use professional judgment.
